My Companies
Notification
Account
Board approved preferential issue of 8,00,000 convertible warrants at Rs 233.05 for Rs 18.64 Cr to Oppbasket (7,00,000) and Sanguine (1,00,000), convertible 1:1 within 18 months. First external top-up since listing; adds non-promoter funding alongside IPO objects. Relevant as working capital absorbs the franchise-led screen ramp and partly relies on customer advances. Subject to EGM on Oct 9 and regulatory approvals; 25% payable on allotment. Use of proceeds, dilution and pricing basis not disclosed; conversion optional over 18 months.